Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-05

Clinical Trial Update: FTIH of ECC4703 in Healthy Volunteers [EARLY_Phase 1]

View source ↗

Summary

The document reports the completion of first-time-in-human Phase 1 testing of ECC4703 in healthy volunteers as part of development for Non-alcoholic Steatohepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ECC4703 (ECC4703)

Snippet

Sponsor: Eccogene | Conditions: Non-alcoholic Steatohepatitis (NASH) | EARLY_Phase 1 | Status: COMPLETED